[go: up one dir, main page]

EE200000138A - Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena - Google Patents

Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Info

Publication number
EE200000138A
EE200000138A EEP200000138A EEP200000138A EE200000138A EE 200000138 A EE200000138 A EE 200000138A EE P200000138 A EEP200000138 A EE P200000138A EE P200000138 A EEP200000138 A EE P200000138A EE 200000138 A EE200000138 A EE 200000138A
Authority
EE
Estonia
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
EEP200000138A
Other languages
English (en)
Inventor
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Andrew Smith Robin
Duke Edward Clarke Geoffrey
Dennis Dowle Michael
Finch Harry
Shah Pritom
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000138A publication Critical patent/EE200000138A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200000138A 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena EE200000138A (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds
PCT/EP1998/005609 WO1999012933A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
EE200000138A true EE200000138A (et) 2001-02-15

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000138A EE200000138A (et) 1997-09-09 1998-09-07 Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena

Country Status (24)

Country Link
EP (1) EP1003748A2 (et)
JP (1) JP2001515904A (et)
KR (1) KR20010023766A (et)
CN (1) CN1278820A (et)
AP (1) AP2000001761A0 (et)
AR (1) AR017072A1 (et)
AU (1) AU9741298A (et)
BR (1) BR9812062A (et)
CA (1) CA2303176A1 (et)
CO (1) CO4970719A1 (et)
EA (1) EA200000204A1 (et)
EE (1) EE200000138A (et)
HU (1) HUP0004644A3 (et)
ID (1) ID24452A (et)
IL (1) IL134791A0 (et)
IS (1) IS5391A (et)
MA (1) MA26543A1 (et)
NO (1) NO20001198L (et)
NZ (1) NZ503130A (et)
PE (1) PE107899A1 (et)
PL (1) PL339176A1 (et)
SK (1) SK3192000A3 (et)
TR (1) TR200000907T2 (et)
WO (1) WO1999012933A2 (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
AU2005231375A1 (en) 2004-03-31 2005-10-20 Janssen Pharmaceutica, N.V. Non-imidazole heterocyclic compounds as histamine H3 receptor modulators
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
TWI355380B (en) * 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ES2328384T3 (es) 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
DE602007009095D1 (de) 2006-05-04 2010-10-21 Pulmagen Therapeutics Inflamma Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
EP4031138A1 (en) 2019-09-17 2022-07-27 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
AU2021256835A1 (en) 2020-04-16 2022-10-13 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
AR006401A1 (es) * 1996-03-28 1999-08-25 Glaxo Group Ltd Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.

Also Published As

Publication number Publication date
IL134791A0 (en) 2001-04-30
PL339176A1 (en) 2000-12-04
CN1278820A (zh) 2001-01-03
NZ503130A (en) 2001-08-31
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
CO4970719A1 (es) 2000-11-07
PE107899A1 (es) 1999-11-17
AR017072A1 (es) 2001-08-22
BR9812062A (pt) 2000-09-26
NO20001198D0 (no) 2000-03-08
KR20010023766A (ko) 2001-03-26
TR200000907T2 (tr) 2000-11-21
AU9741298A (en) 1999-03-29
EA200000204A1 (ru) 2000-10-30
IS5391A (is) 2000-02-29
NO20001198L (no) 2000-05-08
CA2303176A1 (en) 1999-03-18
WO1999012933A2 (en) 1999-03-18
HUP0004644A3 (en) 2002-01-28
AP2000001761A0 (en) 2000-03-31
ID24452A (id) 2000-07-20
MA26543A1 (fr) 2004-12-20
EP1003748A2 (en) 2000-05-31
JP2001515904A (ja) 2001-09-25
HUP0004644A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
FI944804A0 (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
EE9800335A (et) Pürrolopürrolooni derivaadid kui neutrofiilelastaasi inhibiitorid
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
ATE224366T1 (de) D-prolinderivate
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
PT927183E (pt) Inibidores espirociclicos de metaloproteases
FI973211A7 (fi) Ihmisen leukosyyttielastaasin inhibiittoreina hyödylliset proliinijohd annaiset
FI964781A7 (fi) Uusia elastaasi-inhibiittoreita
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE69733263D1 (de) Markierte elastase-inhibitoren
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200100084A (et) NOS inhibiitorite uued farmatseutilised kasutusvoimalused
EE9900585A (et) 6-asauratsiili derivaadid IL-5 inhibiitoritena
ID23866A (id) Komposisi untuk menyelamatkan beras terhadap asetoklor
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1026210A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1026420A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HK1016170A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
BR1100811A (pt) Derivados de 1-metil-carbapenema